Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer
Yanqing Wang(Shanghai Jiao Tong University), Wei Xue(National Sun Yat-sen University), Xiaofei Wen(Shanghai East Hospital), Xiaoguang Shao(Shanghai Jiao Tong University), Chuanyi Hu(Second Military Medical University), Qiang Liu(Sun Yat-sen University), Liancheng Fan(Shanghai Jiao Tong University), Yong Cai(Tongren Hospital), Fan Xu, Wei Chen(Pulmonary and Critical Care Associates), Baijun Dong(Shanghai Jiao Tong University), Jianjun Sha(Shanghai Jiao Tong University), Yinjie Zhu(Shanghai Jiao Tong University), Xun Shangguan(Shanghai Children's Hospital), Zezhou Wang(Ontario Institute for Cancer Research), Jiahua Pan(University of Science and Technology of China)
Cited by 31
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
The Biogenesis of Nascent Circular RNAs
|Cell Reports|2016|694